Table 1 Characterization of the studied population according to the stratification of the lactulose: mannitol ratio.
Variables | L: M ratio | P value | |
|---|---|---|---|
≤ P50 n = 27 | > P50 n = 27 | ||
Socioeconomic profile | |||
Income (BRL), median (Q1–Q3) | 3647 (2500; 11,000) | 5000 (2000; 8000) | 0.938a |
Age (years), mean (SD) | 68 (6) | 69 (7) | 0.460b |
Gender, n (%) | 0.580c | ||
Female | 17 (63%) | 15 (55.6%) | |
Male | 10 (37%) | 12 (44.4%) | |
Race, n (%) | 0.486c | ||
White | 14 (51.9%) | 12 (44.4%) | |
Mixed race | 10 (37%) | 10 (37%) | |
Black | 3 (11.11%) | 5 (18.5%) | |
Education, n (%) | 0.269c | ||
None | 2 (7.4%) | 1 (3.7%) | |
Incomplete elementary school | 1 (3.7%) | 3 (11.11%) | |
Complete elementary school | 6 (22.2%) | 2 (7.4%) | |
Incomplete high school | 3 (11.1%) | - | |
Complete high school | 6 (22.2%) | 7 (25.9%) | |
Complete technical course | 3.7% (1) | 1 (3.7%) | |
Incomplete college | – | – | |
Complete college | 8 (29.6%) | 13 (48.1%) | |
Physical activity practice, n (%) | 0.580c | ||
Yes | 10 (37%) | 12 (44.4%) | |
No | 17 (63%) | 15 (55.6%) | |
Smoking, n (%) | - | ||
Yes | – | – | |
No | 27 (100%) | 27 (100%) | |
Alcohol consumption, n (%) | 0.761c | ||
Yes | 8 (29.6%) | 7 (25.9%) | |
No | 19 (70.4%) | 20 (74.1%) | |
Anthropometric variables | |||
BMI (kg/m2), median (Q1–Q3) | 28.40 (24.54; 33.90) | 25.21 (22.75; 29.85) | 0.050a |
Nutritional status, n (%) | 0.137c | ||
Low weight | 2 (7.4%) | 5 (18.5%) | |
Eutrophic | 9 (33.3%) | 13 (48.1%) | |
Overweight | 16 (59.3%) | 9 (33.3%) | |
Weight (kg), mean (SD) | 75.85 (15.35) | 68.82 (15.56) | 0.261b |
Waist-to-hip ratio, mean (SD) | 0.93 (0.07) | 0.95 (0.07) | 0.221b |
Waist Circumference (cm), mean (SD) | 97.73 (14.32) | 93.97 (9.65) | 0.318b |
Hip Circumference, median (Q1 – Q3) | 105.50 (95; 116) | 96.50 (93; 104) | 0.041a |
Biochemical variables | |||
Triglycerides (mg/dL), median (Q1–Q3) | 128 (93; 215) | 140 (97; 174) | 0.653a |
HDL-c (mg/dL), mean (SD) | 51 (13) | 50 (13) | 0.702b |
LDL-c (mg/dL), mean (SD) | 128.2 (33.7) | 117.8 (47.1) | 0.408b |
VLDL-c (mg/dL), median (Q1–Q3) | 25.40 (18.60; 39.80) | 28 (19.40; 34.80) | 0.852a |
Total Cholesterol (mg/dL), mean (SD) | 209 (37) | 195 (54) | 0.337b |
HOMA-IR, median (Q1–Q3) | 2.45 (1.44; 6.16) | 2.40 (1.54; 4.14) | 0.887a |
HOMA-B, median (Q1–Q3) | 127.60 (94.30; 173.40) | 101.20 (72.30; 152.80) | 0.210a |
Glucose (mg/dL), median (Q1–Q3) | 96 (86; 115) | 99 (89; 108) | 0.315a |
Insulin (mU/dL), median (Q1–Q3) | 11 (6.03; 19.05) | 9 (7; 16) | 0.723a |
Us-CRP (mg/dL), median (Q1–Q3) | 0.15 (0.07; 0,31) | 0.16 (0.13; 0.33) | 0.299a |
Chronic diseases, n (%) | |||
Depression | 5 (18.5%) | 1 (3.7%) | 0.083c |
Migraine | 4 (14.8%) | 1 (3.7%) | 0.159c |
Sinusitis | 4 (14.8%) | 3 (11.1%) | 0.685c |
Lung disease | 2 (7.4%) | 2 (7.4%) | 1.000c |
Hypertension | 16 (59.3%) | 13 (48.1%) | 0.413c |
Diabetes | 5 (18.5%) | 9 (33.3%) | 0.214c |